No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Biomarkers, Tumor / genetics*
-
Clinical Trials, Phase III as Topic
-
Humans
-
Leukemia, Myeloid, Acute / drug therapy*
-
Leukemia, Myeloid, Acute / genetics
-
Leukemia, Myeloid, Acute / mortality
-
Leukemia, Myeloid, Acute / pathology
-
Mutation*
-
Protein Kinase Inhibitors / adverse effects
-
Protein Kinase Inhibitors / therapeutic use*
-
Randomized Controlled Trials as Topic
-
Staurosporine / adverse effects
-
Staurosporine / analogs & derivatives*
-
Staurosporine / therapeutic use
-
Treatment Outcome
-
fms-Like Tyrosine Kinase 3 / genetics*
Substances
-
Antineoplastic Agents
-
Biomarkers, Tumor
-
Protein Kinase Inhibitors
-
FLT3 protein, human
-
fms-Like Tyrosine Kinase 3
-
Staurosporine
-
midostaurin